Eloxatin?/Taxotere? Active for Advanced Non?Small Cell Lung Cancer
August 23rd, 2006
According to an article recently published in the journal Lung Cancer, the chemotherapy combination consisting of Eloxatin? (oxaliplatin) and Taxotere? (docetaxel) is well-tolerated and provides anticancer activity for patients with advanced non?small cell lung cancer.